NEW YORK (GenomeWeb) – Microbiome health management firm DayTwo announced on Tuesday that it has raised $12 million in a Series A financing round. Participants in the round include Johnson & Johnson Innovation-JJDC, Seventure Partners, the Mayo Clinic, DayTwo Cofounder Marius Nacht, and other private investors. DayTwo has raised $17 million to date.
Israeli healthtech DayTwo has raised $12m in a Series A financing round, featuring Johnson & Johnson Innovation-JJDC, the Mayo Clinic, DayTwo Co-founder Marius Nacht and Seventure Partners, to name some. The company is developing an app that will allow users to track their health data on a daily basis, including how much exercise they do, what medications they’re taking, whether they’ve been diagnosed with any chronic disease or The funds will be used to expand the product, as well as add to engineering, and data science teams in Tel Aviv and San Francisco.